CBS and hydrops fetalis: As summarized in Figure 3D, most patients from LF group (89.29%) showed a low cfDNA methylation level of CBS promoter in plasma (LPM group), but less patients from HF group (7.69%) showed a low cfDNA methylation level (P < 0.001).